Touch
Clothing, a blanket, a hand on the skin or massage may become unpleasant or painful.
When the pain system becomes more responsive and the same input suddenly feels much stronger.
The nervous system continually processes signals from the body. In central sensitisation, pain-processing neurons in the central nervous system respond more strongly to normal or even weak input. In everyday language: the alarm system may become more sensitive.
A light or ordinary stimulus may be experienced as much more intense. This “volume control” is only a metaphor: pain is not a simple measurable volume and central sensitisation cannot be read from one scan or one test.
Central sensitisation is a neurophysiological mechanism, not a simple diagnosis that can be proven with one blood test, MRI scan or questionnaire.
IASP stresses that sensitisation in people can only be inferred indirectly from phenomena such as hyperalgesia and allodynia.
Experiences differ. With a more sensitive pain system, input may feel stronger than before, sometimes beyond the place where pain first began.
Clothing, a blanket, a hand on the skin or massage may become unpleasant or painful.
Temperature differences may feel much more intense than they used to.
Some people also report increased sensitivity to light, sound or smells.
Disturbed sleep, fatigue and concentration problems often occur alongside features of nociplastic pain.
We know a fair amount about chronic pain, but there is no reliable general prevalence figure for central sensitisation itself. A major reason is that there is no gold-standard test that gives a simple yes-or-no answer in a person.
of the European population lives with chronic pain according to the Dutch guideline.
This concerns chronic pain overall, not central sensitisation.of people aged 12 and over reported in 2021 that pain interfered with normal activities.
Dutch guideline, based on Statistics Netherlands data.was the range across individual studies of “presumed central sensitisation”, depending on method and study population.
This is not a prevalence estimate for the general population.of 2,347 participants with chronic low-back pain scored above a commonly used CSI cut-off in a systematic review.
A CSI score is a screening measure, not a direct physiological measurement.A questionnaire, pressure-pain threshold and response to repeated stimuli measure different things. The wide range is itself a warning against a spectacular claim that “x% have central sensitisation”.
Central sensitisation is often mentioned alongside nociplastic pain, but the terms are not exact synonyms. These mechanisms can also coexist.
Pain from actual or threatened damage to non-neural tissue, with activation of nociceptors.
For example, a wound or inflamed joint.
Pain caused by a lesion or disease of the somatosensory nervous system.
For example, certain forms of nerve damage.
Pain arising from altered nociception without clear evidence that tissue damage or a nerve lesion fully explains it.
Central and/or peripheral sensitisation may play a role.
A person may have demonstrable physical damage and altered pain processing at the same time. “Something is visible on the scan” and “the nervous system has become more sensitive” do not automatically exclude one another.
There is no single cause and no simple rule that long-lasting pain automatically leads to central sensitisation. Research points to several processes that may influence pain processing and modulation.
A simplified model. These factors do not prove that any one factor caused the mechanism in an individual.
There is no gold standard that directly establishes central sensitisation in a person. Clinicians therefore consider the overall pain pattern and indirect indications.
Has the pain become regional, multifocal or widespread? Is its intensity fully explained by one known cause?
Responses to touch, pressure, temperature or repeated stimuli can provide indirect clues.
The Central Sensitization Inventory (CSI) can map symptoms, but does not directly measure whether central nervous system neurons are sensitised.
A questionnaire may help identify a broad symptom pattern. It is too strong to conclude from one score that central sensitisation has been physiologically “proven”.
No treatment “resets a sensitive nervous system” for everyone. The approach depends on the pain type, other conditions, capacity and what someone needs in order to function better.
New or clearly changed symptoms deserve ordinary medical assessment. The label “sensitisation” should not stop further clinical thinking.
Guidelines recommend physical activity and, where appropriate, supervised exercise for chronic primary pain—adapted to goals and capacity, not simply “pushing through”.
Sleep disturbance and fatigue may form part of the broader picture and belong in assessment and treatment planning.
NICE lists Acceptance and Commitment Therapy and cognitive behavioural therapy for pain as possible options for chronic primary pain.
No medicine “cures central sensitisation”. Choice depends on the particular pain condition, other illnesses, benefits and adverse effects.
In complex chronic pain, physical, psychological and social factors may all be relevant. Collaboration between professionals can then be useful.
Since April 2026, reimbursement conditions for interdisciplinary specialist medical rehabilitation (IMSR) for chronic pain have changed. IMSR is no longer automatically covered for people who have not completed a full primary-care programme. Temporary coverage remains possible for a group whose primary-care treatment was insufficient while further research is conducted.
This is information about the Dutch healthcare system, not individual treatment advice.
With persistent pain, the first goal is not always reaching “zero pain”. More control, better functioning, fewer setbacks and room for meaningful activities may be valuable outcomes. What helps differs between people.
A general self-management structure, not a personal medical treatment plan.
They may be helpful for some people, but evidence is not strong enough to call them the treatment for central sensitisation. Use them as optional tools, not as a compulsory nervous-system “reset”.
A plan can also aim at better sleep, more movement, less fear of activity, greater independence, work or participation in family life. Pain reduction is welcome, but not the only measure of success.
It can provide words for a real experience: the pain is genuine, while more may be happening than only at the place that hurts.
“It is central sensitisation” must not mean that every new symptom is automatically attributed to the same mechanism. A person with a sensitive pain system can still develop a new, treatable condition.
We want to understand how central sensitisation is explained in practice and what happens afterwards—not to collect diagnoses, but to make patterns in care pathways visible.
Share your experience with ZorgfuikThis uses the existing general experience form.